Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Journal of psychopharmacology (Oxford, England)
Date
2016-12-01
Source
PubMed
DOI
10.1177/0269881116678781
PubMed
27856683
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:27 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01Mystical experiences mediate the effects of psilocybin-assisted psychotherapy + mindfulness-based stress reduction on trait mindfulness and depression symptoms: mechanistic results from a randomized controlled trial2026-10-11Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD2026-09-08Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study2026-07-01A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience2026-04-14Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol2026-04-13Pilot study of psilocybin in patients with post-treatment lyme disease2026-02-25Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study2026-01-18Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study2025-12-19Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects2025-11-30Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience2025-11-20Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis2025-04-24Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey2025-04-22Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?2025-01-21Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms2024-09-09PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin2024-07-24Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression2024-04-15A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes2024-04-05Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder2024-03-07Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol2023-10-25

Related papers

No close related records were found yet.